8.32
price up icon2.46%   0.20
after-market アフターアワーズ: 8.32
loading
前日終値:
$8.12
開ける:
$8.29
24時間の取引高:
92,683
Relative Volume:
0.68
時価総額:
$315.74M
収益:
$239.40M
当期純損益:
$104.44M
株価収益率:
2.8108
EPS:
2.96
ネットキャッシュフロー:
$-18.50M
1週間 パフォーマンス:
+9.47%
1か月 パフォーマンス:
-0.12%
6か月 パフォーマンス:
-61.46%
1年 パフォーマンス:
-47.34%
1日の値動き範囲:
Value
$8.29
$8.59
1週間の範囲:
Value
$7.62
$8.59
52週間の値動き範囲:
Value
$7.10
$21.79

Entrada Therapeutics Inc Stock (TRDA) Company Profile

Name
名前
Entrada Therapeutics Inc
Name
セクター
Healthcare (1171)
Name
電話
857-305-1825
Name
住所
ONE DESIGN CENTER PLACE, BOSTON
Name
職員
183
Name
Twitter
Name
次回の収益日
2024-08-12
Name
最新のSEC提出書
Name
TRDA's Discussions on Twitter

TRDA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TRDA
Entrada Therapeutics Inc
8.32 299.83M 239.40M 104.44M -18.50M 2.96
Biotechnology icon
ONC
Beone Medicines Ltd Adr
255.86 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.50 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.232 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.34 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
493.22 65.36B 14.09B 4.50B 2.96B 39.28

Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-06 開始されました ROTH MKM Buy
2024-01-05 開始されました Oppenheimer Outperform
2023-04-03 開始されました H.C. Wainwright Buy

Entrada Therapeutics Inc (TRDA) 最新ニュース

pulisher
05:37 AM

Mackenzie Financial Corp Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

05:37 AM
pulisher
Jun 05, 2025

How the (TRDA) price action is used to our Advantage - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 04, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock Position Trimmed by Nuveen Asset Management LLC - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Entrada Therapeutics expands board with new director By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Entrada Therapeutics expands board with new director - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Entrada Therapeutics (TRDA) Welcomes New Board Member | TRDA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Entrada Therapeutics Appoints New Board Member - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

3,324 Shares in Entrada Therapeutics, Inc. (NASDAQ:TRDA) Bought by BNP Paribas Financial Markets - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Buys 2,517 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Buy Rating for Entrada Therapeutics: Strategic Positioning and Regulatory Advances in Exon-Skipping Therapeutics - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan - Stock Titan

Jun 02, 2025
pulisher
May 31, 2025

Deutsche Bank AG Grows Stock Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 31, 2025
pulisher
May 29, 2025

Entrada Therapeutics to start DMD trial in Q3 2025 By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Entrada Therapeutics (TRDA) Gains EU Approval for Advanced Clinical Study | TRDA Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Entrada Therapeutics to start DMD trial in Q3 2025 - Investing.com

May 28, 2025
pulisher
May 28, 2025

Entrada Therapeutics Receives EU Authorization to Proceed with ELEVATE-45-201 Clinical Study for Duchenne Muscular Dystrophy, Set to Begin in Q3 2025 - Nasdaq

May 28, 2025
pulisher
May 28, 2025

Breakthrough DMD Treatment Gets EU Green Light: Entrada's Novel Exon 45 Therapy Heads to Clinical Trials - Stock Titan

May 28, 2025
pulisher
May 23, 2025

HC Wainwright Brokers Boost Earnings Estimates for TRDA - Defense World

May 23, 2025
pulisher
May 22, 2025

Layoff Tracker: Boundless Laying Off 33% of Staff - BioSpace

May 22, 2025
pulisher
May 22, 2025

Q2 Earnings Forecast for TRDA Issued By HC Wainwright - Defense World

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Reiterates Buy Rating for Entrada Therapeutics (NASDAQ:TRDA) - Defense World

May 22, 2025
pulisher
May 21, 2025

Northern Trust Corp Has $5.50 Million Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 21, 2025
pulisher
May 20, 2025

Entrada Therapeutics (TRDA) Receives 'Buy' Rating Reiteration by HC Wainwright | TRDA Stock News - GuruFocus

May 20, 2025
pulisher
May 17, 2025

Tower Research Capital LLC TRC Cuts Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 17, 2025
pulisher
May 15, 2025

(TRDA) Technical Pivots with Risk Controls - news.stocktradersdaily.com

May 15, 2025
pulisher
May 15, 2025

Roth Capital Issues Negative Outlook for TRDA Earnings - Defense World

May 15, 2025
pulisher
May 14, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Dimensional Fund Advisors LP - Defense World

May 14, 2025
pulisher
May 12, 2025

Entrada Therapeutics price target lowered to $21 from $23 at Roth Capital - TipRanks

May 12, 2025
pulisher
May 12, 2025

Entrada Therapeutics (TRDA) Sees Price Target Adjustment Amid Cl - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Roth Capital Adjusts Price Target for Entrada Therapeutics (TRDA - GuruFocus

May 12, 2025
pulisher
May 11, 2025

Roth Capital Adjusts Price Target for Entrada Therapeutics (TRDA) | TRDA Stock News - GuruFocus

May 11, 2025
pulisher
May 11, 2025

Analysts Are Upgrading Entrada Therapeutics, Inc. (NASDAQ:TRDA) After Its Latest Results - Yahoo Finance

May 11, 2025
pulisher
May 08, 2025

Entrada Therapeutics: Strategic Advancements in DMD Pipeline Drive Buy Rating - TipRanks

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics reports Q1 EPS (42c), consensus (77c) - TipRanks

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics earnings beat by $0.31, revenue fell short of estimates - Investing.com

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics (TRDA) Reports Strong Q1 Revenue and Advances Duchenne Programs | TRDA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics, Inc. (TRDA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Entrada Therapeutics Reports First Quarter 2025 Financial Results - The Manila Times

May 08, 2025
pulisher
May 08, 2025

First Trust Advisors LP Sells 7,800 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 08, 2025
pulisher
May 08, 2025

MetLife Investment Management LLC Acquires 1,731 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 08, 2025
pulisher
May 08, 2025

Wells Fargo & Company MN Buys 3,357 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 08, 2025
pulisher
May 06, 2025

Barclays PLC Has $887,000 Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 06, 2025
pulisher
May 06, 2025

Analysts Are Bullish on Top Healthcare Stocks: ImmunityBio (IBRX), Axsome Therapeutics (AXSM) - The Globe and Mail

May 06, 2025
pulisher
May 05, 2025

Form 8-KCurrent report - ADVFN

May 05, 2025
pulisher
May 05, 2025

Finance Watch: Unity Lays Off All Employees As It Evaluates Alternatives - insights.citeline.com

May 05, 2025
pulisher
May 05, 2025

Invesco Ltd. Takes Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

May 05, 2025
pulisher
May 05, 2025

Entrada Therapeutics (TRDA) Projected to Post Earnings on Tuesday - Defense World

May 05, 2025
pulisher
May 01, 2025

Analysts Estimate Entrada Therapeutics, Inc. (TRDA) to Report a Decline in Earnings: What to Look Out for - MSN

May 01, 2025

Entrada Therapeutics Inc (TRDA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.15
price up icon 0.00%
$585.93
price up icon 0.92%
$300.83
price down icon 2.33%
$38.11
price up icon 4.29%
$4.73
price down icon 1.69%
$493.22
price up icon 2.10%
大文字化:     |  ボリューム (24 時間):